Targeting Alzheimer’s Disease: A New Wave
The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even …
All Posts
Experts state contract services sector the big winner of pandemic at CPhI Discover
Near-term capacity constraints for recombinant vector manufacturing, with continuous bioprocessing & process intensification set for rapid growth in next 5-10 …
Vaccine Passports in NHS app unethical if they don’t allow date custodianship say FarmaTrust
Blockchain, not the NHS app, is the obvious overlooked answer to security and custodianship
CMED GROUP joins AIXIAL GROUP, the CRO of ALTEN GROUP
AIXIAL GROUP becomes a leading mid-size, worldwide CRO with strong US and European presence and more than 1,000 employees.
CD BioSciences Provides Case Report Form Design Service for Clinical Trials
CD BioSciences, a supplier of one-stop clinical trial services based in the United States, has released its case report form …
CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted
CPhI Japan Connect continues until the end of May
PARADIGM4 UNVEILS NEW ANALYTICAL DEVELOPMENT DATA MANAGEMENT TOOL TO UNLOCK ALLOTROPE DATA FORMAT ‘TREASURE TROVE’
Paradigm4 unveiled its scalable solution for efficiently working with the Allotrope Data Format (ADF) at the Allotrope Foundation’s Spring Connect …
Aigenpulse launches CytoML 5.2: automated flow cytometry with unbiased analysis
Aigenpulse has rolled out an update to its CytoML Experiment Suite – its automated, end-to-end, machine learning solution specifically aimed …
CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth
Executives are extremely bullish on pharma’s business outlook for both the short and medium term
Powered by Venture Funding, the Microbiome Market is Ready for Mainstream
2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome …
ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers
The collaboration will improve visibility and reporting of cell and gene therapy manufacturing through a pre-integrated data solution
Promega launches XpressAmp™ Direct Amplification Reagents
COVID-19 testing labs can now skip RNA extraction, simplifying and accelerating workflows
